Cargando…

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study

INTRODUCTION: Group A β-haemolytic Streptococcus (GAS), a Gram-positive bacterium, also known as Streptococcus pyogenes, causes pyoderma, pharyngitis and invasive disease. Repeated GAS infections may lead to autoimmune diseases such as acute post-streptococcal glomerulonephritis, acute rheumatic fev...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Dylan D, Engel, Mark E, Whitelaw, Andrew, Alemseged, Abdissa, Sadoh, Wilson E, Ali, Sulafa K M, Sow, Samba O, Dale, James, Mayosi, Bongani M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769387/
https://www.ncbi.nlm.nih.gov/pubmed/26916694
http://dx.doi.org/10.1136/bmjopen-2015-010248
_version_ 1782418096052502528
author Barth, Dylan D
Engel, Mark E
Whitelaw, Andrew
Alemseged, Abdissa
Sadoh, Wilson E
Ali, Sulafa K M
Sow, Samba O
Dale, James
Mayosi, Bongani M
author_facet Barth, Dylan D
Engel, Mark E
Whitelaw, Andrew
Alemseged, Abdissa
Sadoh, Wilson E
Ali, Sulafa K M
Sow, Samba O
Dale, James
Mayosi, Bongani M
author_sort Barth, Dylan D
collection PubMed
description INTRODUCTION: Group A β-haemolytic Streptococcus (GAS), a Gram-positive bacterium, also known as Streptococcus pyogenes, causes pyoderma, pharyngitis and invasive disease. Repeated GAS infections may lead to autoimmune diseases such as acute post-streptococcal glomerulonephritis, acute rheumatic fever (ARF) and rheumatic heart disease (RHD). Invasive GAS (iGAS) disease is an important cause of mortality and morbidity worldwide. The burden of GAS infections is, however, unknown in Africa because of lack of surveillance systems. METHODS AND ANALYSIS: The African group A streptococcal infection registry (the AFROStrep study) is a collaborative multicentre study of clinical, microbiological, epidemiological and molecular characteristics for GAS infection in Africa. The AFROStrep registry comprises two components: (1) active surveillance of GAS pharyngitis cases from sentinel primary care centres (non-iGAS) and (2) passive surveillance of iGAS disease from microbiology laboratories. Isolates will also be subjected to DNA isolation to allow for characterisation by molecular methods and cryopreservation for long-term storage. The AFROStrep study seeks to collect comprehensive data on GAS isolates in Africa. The biorepository will serve as a platform for vaccine development in Africa. ETHICS AND DISSEMINATION: Ethics approval for the AFROStrep registry has been obtained from the Human Research Ethics Committee at the University of Cape Town (HREC/REF: R006/2015). Each recruiting site will seek ethics approval from their local ethics’ committee. All participants will be required to provide consent for inclusion into the registry as well as for the storage of isolates and molecular investigations to be conducted thereon. Strict confidentiality will be applied throughout. Findings and updates will be disseminated to collaborators, researchers, health planners and colleagues through peer-reviewed journal articles, conference publications and proceedings.
format Online
Article
Text
id pubmed-4769387
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47693872016-03-01 Rationale and design of the African group A streptococcal infection registry: the AFROStrep study Barth, Dylan D Engel, Mark E Whitelaw, Andrew Alemseged, Abdissa Sadoh, Wilson E Ali, Sulafa K M Sow, Samba O Dale, James Mayosi, Bongani M BMJ Open Epidemiology INTRODUCTION: Group A β-haemolytic Streptococcus (GAS), a Gram-positive bacterium, also known as Streptococcus pyogenes, causes pyoderma, pharyngitis and invasive disease. Repeated GAS infections may lead to autoimmune diseases such as acute post-streptococcal glomerulonephritis, acute rheumatic fever (ARF) and rheumatic heart disease (RHD). Invasive GAS (iGAS) disease is an important cause of mortality and morbidity worldwide. The burden of GAS infections is, however, unknown in Africa because of lack of surveillance systems. METHODS AND ANALYSIS: The African group A streptococcal infection registry (the AFROStrep study) is a collaborative multicentre study of clinical, microbiological, epidemiological and molecular characteristics for GAS infection in Africa. The AFROStrep registry comprises two components: (1) active surveillance of GAS pharyngitis cases from sentinel primary care centres (non-iGAS) and (2) passive surveillance of iGAS disease from microbiology laboratories. Isolates will also be subjected to DNA isolation to allow for characterisation by molecular methods and cryopreservation for long-term storage. The AFROStrep study seeks to collect comprehensive data on GAS isolates in Africa. The biorepository will serve as a platform for vaccine development in Africa. ETHICS AND DISSEMINATION: Ethics approval for the AFROStrep registry has been obtained from the Human Research Ethics Committee at the University of Cape Town (HREC/REF: R006/2015). Each recruiting site will seek ethics approval from their local ethics’ committee. All participants will be required to provide consent for inclusion into the registry as well as for the storage of isolates and molecular investigations to be conducted thereon. Strict confidentiality will be applied throughout. Findings and updates will be disseminated to collaborators, researchers, health planners and colleagues through peer-reviewed journal articles, conference publications and proceedings. BMJ Publishing Group 2016-02-25 /pmc/articles/PMC4769387/ /pubmed/26916694 http://dx.doi.org/10.1136/bmjopen-2015-010248 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Epidemiology
Barth, Dylan D
Engel, Mark E
Whitelaw, Andrew
Alemseged, Abdissa
Sadoh, Wilson E
Ali, Sulafa K M
Sow, Samba O
Dale, James
Mayosi, Bongani M
Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title_full Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title_fullStr Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title_full_unstemmed Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title_short Rationale and design of the African group A streptococcal infection registry: the AFROStrep study
title_sort rationale and design of the african group a streptococcal infection registry: the afrostrep study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769387/
https://www.ncbi.nlm.nih.gov/pubmed/26916694
http://dx.doi.org/10.1136/bmjopen-2015-010248
work_keys_str_mv AT barthdyland rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT engelmarke rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT whitelawandrew rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT alemsegedabdissa rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT sadohwilsone rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT alisulafakm rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT sowsambao rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT dalejames rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy
AT mayosibonganim rationaleanddesignoftheafricangroupastreptococcalinfectionregistrytheafrostrepstudy